Medical Polymers Market

Pharmaceutical Polymers / Medical Polymers Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Others), Area of Application and Key Geographical Regions

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    176

  • Pages
    205

  • View Count
    12547

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Polymers
3.2.1 Historical Development of Polymers
3.2.2 Properties of Polymers
3.2.2.1 Physical Properties
3.2.2.1 Chemical Properties
3.2.2.2 Mechanical Properties

3.2.3 Classification of Polymers
3.2.3.1 Classification based on Molecular Forces
3.2.3.2 Classification based on Origin of Source
3.2.3.3 Classification based on Structure of Molecular Chain 
3.2.3.4 Classification based on Monomers
3.2.3.5 Classification based on Backbone Chain
3.2.3.6 Classification based on Degradation Capability
3.2.3.7 Classification based on Morphology

3.2.4 Applications of Polymers in Pharmaceutical / Medical Domain
3.2.4.1 Pharmaceutical Formulation
3.2.4.2 Drug Delivery System
3.2.4.3 Gene Therapy
3.2.4.4 Stability Enhancer
3.2.4.5 Vaccine Adjuvant
3.2.4.6 Tissue Engineering
3.2.4.7 Dentistry
3.2.4.8 Packaging
3.2.4.9 Medical Device Coating
3.2.4.10 Others

3.3. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Source of Polymer
4.2.6. Analysis by Composition of Polymer
4.2.7. Analysis by Type of Polymer
4.2.8. Analysis by Area of Application

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the World

6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. Eastman
6.4.1. Company Overview
6.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Lubrizol Life Science
6.5.1. Company Overview
6.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. LyondellBasell
6.6.1. Company Overview
6.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook

7.3. Henkel
7.3.1. Company Overview
7.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.3.3. Recent Developments and Future Outlook

7.4. KRAIBURG TPE
7.4.1. Company Overview
7.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.4.3. Recent Developments and Future Outlook

7.5. SEQENS
7.5.1. Company Overview
7.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.5.3. Recent Developments and Future Outlook

7.6. Solvay
7.6.1. Company Overview
7.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook

8.3. Kuraray
8.3.1. Company Overview
8.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.3.3. Recent Developments and Future Outlook

8.4. Phon Tech
8.4.1. Company Overview
8.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. Sumitomo Chemical
8.5.1. Company Overview
8.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. Zylog ElastoComp
8.6.1. Company Overview
8.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.6.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Composition of Polymer
9.3.5. Analysis by Type of Polymer
9.3.6. Analysis by Type of Partnership and Type of Polymer
9.3.7. Analysis by Area of Application
9.3.8. Analysis by Type of Partner
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Intracontinental and Intercontinental Deals
9.3.10.2. International and Local Deals

10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview 
10.2. Methodology 
10.3. Key Parameters
10.3.1. Demographical Factors
10.3.2. Environmental Factors
10.3.3. Legal Factors
10.3.4. Technological Factors

10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.4.1. Arkema
10.4.2. Boron Molecular
10.4.3. Celanese
10.4.4. Chempilots
10.4.5. DSM
10.4.6. Evonik
10.4.7. Foryou Medical
10.4.8. JenKem Technology
10.4.9. Kraton
10.4.10. Kuraray
10.4.11. PolyVation
10.4.12. Polyzen
10.4.13. Zylog ElastoComp

10.5. Concluding Remarks

11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1 Chapter Overview
11.2 Recent Trends Related to Pharmaceutical / Medical Polymers
11.2.1 Development of Novel Pharmaceutical / Medical Polymers
11.2.1.1. Biodegradable Polymers
11.2.1.2. Smart Polymers
11.2.2. Recycling of Pharmaceutical / Medical Polymers
11.3. Concluding Remarks

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
12.3.1. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Type of Polymer, 2023 and 2035
12.3.1.1. Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035
12.3.1.2. Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035
12.3.1.3. Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035
12.3.1.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.2. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Area of Application, 2023 and 2035
12.3.2.1. Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035
12.3.2.2. Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035
12.3.2.3. Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035
12.3.2.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035

12.3.3. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Geography, 2023 and 2035
12.3.3.1. Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035
12.3.3.2. Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Asia-Pacific, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cassion Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript

14.3. Celares
14.3.1. Company Snapshot
14.3.2. Interview Transcript

14.4. Daikyo Seiko
14.4.1. Company Snapshot
14.4.2. Interview Transcript

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS 

List Of Figures

Figure 2.1. Executive Summary: Overall Market Landscape
Figure 2.2. Executive Summary: Partnerships and Collaborations
Figure 2.3. Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Formation of Polymers
Figure 3.2 Historical Development of Polymers
Figure 3.3 Classification of Polymers
Figure 3.4 Applications of Polymers in Pharmaceutical Domain
Figure 4.1 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Year of Establishment
Figure 4.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size
Figure 4.3 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Source of Polymer
Figure 4.7 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Composition of Polymer
Figure 4.8 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Number of Compositions of Polymer
Figure 4.9 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Type of Polymer
Figure 4.10 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Area of Application
Figure 5.1 Company Competitiveness Analysis: Players based in North America 
Figure 5.2 Company Competitiveness Analysis: Players based in Europe
Figure 5.3 Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the world
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Composition of Polymer
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Polymer
Figure 9.7 Partnerships and Collaborations: Distribution by Area of Application
Figure 9.8 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.9 Most Active Players: Distribution by Number of Partnerships
Figure 9.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.11 Partnerships and Collaborations: Local and International Agreements
Figure 10.1 DELT Analysis: Impact of Internal and External Factors
Figure 10.2 DELT Analysis: Key Parameters
Figure 10.3 DELT Analysis: Arkema
Figure 10.4 DELT Analysis: Boron Molecular
Figure 10.5 DELT Analysis: Celanese
Figure 10.6 DELT Analysis: Chempilots
Figure 10.7 DELT Analysis: DSM
Figure 10.8 DELT Analysis: Evonik
Figure 10.9 DELT Analysis: Foryou Medical
Figure 10.10 DELT Analysis: JenKem Technology
Figure 10.11 DELT Analysis: Kraton
Figure 10.12 DELT Analysis: Kuraray
Figure 10.13 DELT Analysis: PolyVation
Figure 10.14 DELT Analysis: Polyzen
Figure 10.15 DELT Analysis: Zylog ElastoComp
Figure 10.16 DELT Analysis: Concluding Remarks
Figure 11.1 Types of Smart Polymers
Figure 12.1 Global Pharmaceutical Polymers / Medical Polymers Market, 2023-2035 (USD Billion)
Figure 12.2 Pharmaceutical Polymers / Medical Polymers Market, 2023 and 2035: Distribution by Type of Polymer
Figure 12.3 Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035 (USD Billion)
Figure 12.4 Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035 (USD Billion)
Figure 12.5 Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035 (USD Billion)
Figure 12.6 Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035 (USD Billion)
Figure 12.7 Pharmaceutical Polymers / Medical Polymers Market, 2023 and 2035: Distribution by Area of Application
Figure 12.8 Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035 (USD Billion)
Figure 12.9 Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035 (USD Billion)
Figure 12.10 Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035 (USD Billion)
Figure 12.11 Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035 (USD Billion)
Figure 12.12 Pharmaceutical Polymers / Medical Polymers Market, Distribution by Geography, 2023 and 2035
Figure 12.13 Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035 (USD Billion)
Figure 12.14 Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035 (USD Billion)
Figure 12.15 Pharmaceutical Polymers / Medical Polymers Market in Asia Pacific, 2023-2035 (USD Billion)
Figure 12.16 Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035 (USD Billion)
Figure 12.17 Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035 (USD Billion)
Figure 13.1 Concluding Remarks: Overall Market Landscape
Figure 13.2 Concluding Remarks: Company Competitiveness Analysis
Figure 13.3 Concluding Remarks: Partnership and Collaborations
Figure 13.4 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 4.1 Pharmaceutical Polymers / Medical Polymers: List of Manufacturers
Table 4.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Information on Type of Polymer, Method of Processing, Method of Sterilization and Area of Application
Table 4.3 Pharmaceutical Polymer / Medical Polymers Manufacturers: Information on Area of Application
Table 6.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in North America
Table 6.2 Americhem: Company Snapshot
Table 6.3 Americhem: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.4 Americhem: Recent Developments and Future Outlook
Table 6.5 Celanese: Company Snapshot
Table 6.6 Celanese: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.7 Celanese: Recent Developments and Future Outlook
Table 6.8 Eastman: Company Snapshot
Table 6.9 Eastman: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.10 Eastman: Recent Developments and Future Outlook
Table 6.11 Lubrizol Life Science: Company Snapshot
Table 6.12 Lubrizol Life Science: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.13 Lubrizol Life Science: Recent Developments and Future Outlook
Table 6.14 LyondellBasell: Company Snapshot
Table 6.15 LyondellBasell: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.16 LyondellBasell: Recent Developments and Future Outlook
Table 7.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in Europe
Table 7.2 Borealis: Company Snapshot
Table 7.3 Borealis: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.4 Borealis: Recent Developments and Future Outlook
Table 7.5 Henkel: Company Snapshot
Table 7.6 Henkel: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.7 Henkel: Recent Developments and Future Outlook
Table 7.8 KRAIBURG TPE: Company Snapshot
Table 7.9 KRAIBURG TPE: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.10 KRAIBURG TPE: Recent Developments and Future Outlook
Table 7.11 SEQENS: Company Snapshot
Table 7.12 SEQENS: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.13 SEQENS: Recent Developments and Future Outlook
Table 7.14 Solvay: Company Snapshot
Table 7.15 Solvay: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.16 Solvay: Recent Developments and Future Outlook
Table 8.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in Asia-Pacific
Table 8.2 Corel Pharma Chem: Company Snapshot
Table 8.3 Corel Pharma Chem: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.4 Kuraray: Company Snapshot
Table 8.5 Kuraray: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.6 Phon Tech: Company Snapshot
Table 8.7 Phon Tech: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.8 Sumitomo Chemical: Company Snapshot
Table 8.9 Sumitomo Chemical: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.10 Zylog ElastoComp: Company Snapshot
Table 8.11 Zylog ElastoComp: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 9.1 Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations, 2019-2022
Table 10.1 DELT Analysis: Impact of Internal and External Factors on Leading Players
Table 11.1 Pharmaceutical Polymers / Medical Polymers: List of Biodegradable Polymers
Table 14.1 Caisson Biotech: Company Snapshot
Table 14.2 Celares: Company Snapshot
Table 14.3 Daikyo Seiko: Company Snapshot
Table 15.1 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Year of Establishment
Table 15.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size
Table 15.3 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 15.4 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size and Location of Headquarters
Table 15.6 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Source of Polymer
Table 15.7 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Composition of Polymer
Table 15.8 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Number of Composition of Polymer
Table 15.9 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Type of Polymer
Table 15.10 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Area of Application
Table 15.11 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2022
Table 15.12 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.14 Partnerships and Collaborations: Distribution by Composition of Polymer
Table 15.15 Partnerships and Collaborations: Distribution by Type of Polymer
Table 15.16 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Polymer
Table 15.17 Partnerships and Collaborations: Distribution by Area of Application
Table 15.18 Partnerships and Collaborations: Distribution by Type of Partner
Table 15.19 Most Active Players: Distribution by Number of Partnerships
Table 15.20 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.21 Partnerships and Collaborations: International and Local Agreements
Table 15.22 Global Pharmaceutical Polymers / Medical Polymers Market: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.23 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Type of Polymer, 2023-2035
Table 15.24 Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.25 Pharmaceutical Polymers / Medical Polymers Market for Elastomers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.26 Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.27 Pharmaceutical Polymers / Medical Polymers Market for Others: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.28 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Area of Application, 2023-2035
Table 15.29 Pharmaceutical Polymers / Medical Polymers Market for Medical Devices: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.30 Pharmaceutical Polymers / Medical Polymers Market for Excipients: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.31 Pharmaceutical Polymers / Medical Polymers Market for Packaging: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.32 Pharmaceutical Polymers / Medical Polymers Market for Others: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.33 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Geography, 2023-2035
Table 15.34 Pharmaceutical Polymers / Medical Polymers Market in North America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.35 Pharmaceutical Polymers / Medical Polymers Market in Europe: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.36 Pharmaceutical Polymers / Medical Polymers Market in Asia Pacific: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.37 Pharmaceutical Polymers / Medical Polymers Market in Latin America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.38 Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. Advanced Biopolymers
  2. AdvanSource Biomaterials (Acquired by Mitsubishi Chemical)
  3. Aerosint
  4. AgraTech International
  5. Americhem
  6. Amishi Drugs & Chemicals
  7. Ankit Pulps and Boards
  8. Arkema
  9. Aromatic Cellulose
  10. Asha Cellulose (India)
  11. Ashland
  12. Athos Collagen
  13. Atom pharma
  14. Avantor
  15. AVROXA
  16. B. Braun
  17. BASF
  18. Biesterfeld
  19. BIMAX (Acquired by Mitsubishi Chemical)
  20. BIO21 company
  21. Biomerics
  22. Borealis
  23. Boron Molecular
  24. Bracell 
  25. BSA Pharma
  26. CD BioGlyco
  27. Celanese
  28. Celares
  29. Cellulose Solutions
  30. Celotech Chemical
  31. ChemCon
  32. Chemfield Cellulose
  33. Chempilots
  34. Chibio Biotech
  35. ChitoLytic
  36. Clariant
  37. Colorcon
  38. Controlled Polymers (Acquired by Americhem)
  39. Corbion
  40. Corel Pharma Chem
  41. Cornileus Pharmaceuticals
  42. Covestro
  43. Custom Collagen
  44. Daikyo Seiko
  45. Dependable Plastics (Acquired by Biomerics)
  46. Dhara Lifescience
  47. Doshion Polyscience
  48. Dow
  49. DSM
  50. DuPont
  51. DURECT
  52. Eastman
  53. EirMed (Acquired by Trelleborg Sealing Solutions)
  54. ELIX Polymers (Acquired by Sinochem International)
  55. Elkem
  56. EMS-GRIVORY
  57. EnCom Polymers
  58. Ensinger
  59. Evonik
  60. ExxonMobil
  61. Foodmate
  62. Formosa Plastics
  63. Foryou Medical
  64. Foster
  65. Franplast
  66. Funingpu (FNP)
  67. Gelest (Acquired by Mitsubishi Chemical)
  68. GoLong™ Cellulose
  69. Gelatin Representatives of the World (GROW)
  70. Haiyang Zhouji Seaweed
  71. Hapco, Inc
  72. Henkel
  73. Heppe Medical Chitosan
  74. Honeywell 
  75. Hunstman
  76. Hyosung Chemical
  77. Ideal Cures (IC)
  78. IMCD
  79. INEOS
  80. International Flavors & Fragrances (IFF)
  81. Invibio Biomaterial Solutions (A subsidiary of Victrex )
  82. INVISTA
  83. IRO Alginate Industry
  84. Italgel (Acquired by Bregal)
  85. Jellice Pioneer Europe
  86. JenKem Technology
  87. JRS Pharma
  88. Juncà Gelatines (Acquired by Lapi Gelatine)
  89. Kenney & Ross (K&R)
  90. KIMICA
  91. KRAIBURG TPE
  92. Kraton
  93. Kuraray
  94. Lapi Gelatine
  95. LOTTE Chemical 
  96. Lubrizol Life Science
  97. Lycolab 
  98. LyondellBasell
  99. M. Holland
  100. Meito Sangyo
  101. Meron
  102. Meros Polymers
  103. Michelin
  104. Mitsubishi Chemical Performance Polymers (MCPP) (A subsidiary of Mitsubishi Chemical Group)
  105. MSA
  106. MSA Cellulose Products
  107. Nationwide Children's Hospital
  108. Neelkanth Polymer Industries
  109. Netkanika 
  110. Nexa3D
  111. Nexeo Plastics
  112. Next Polymers (Acquired by Celanese)
  113. Nitta Gelatin
  114. NOF AMERICA CORPORATION (A subsidiary of NOF CORPORATION)
  115. OSTIUM Group
  116. Ott Scientific
  117. PB Leiner 
  118. Pharmacosmos
  119. Phon Tech
  120. Photanol
  121. pK Chemicals
  122. Plastic Energy
  123. PMC Isochem
  124. Poly-Med
  125. Polysciences
  126. Polysil (Acquired by Elkem) 
  127. PolyVation
  128. Polyzen (Acquired by Solesis)
  129. Premix Group
  130. PrinterPrezz
  131. ProMed Pharma
  132. Rayonier Advanced Materials (RYAM)
  133. REINERT Gruppe Ingredients
  134. RENOLIT Healthcare
  135. Repsol
  136. ResMart
  137. Restoration Medical Polymers (RMP)
  138. Rochling
  139. Röhm 
  140. Rousselot
  141. S.R.K. Enterprises
  142. SABIC
  143. Santosh Group
  144. Secant
  145. SEQENS
  146. Shandong Jiejing
  147. Shenzhen Haosu Industrial
  148. Shin-Etsu Chemical
  149. SIBUR
  150. Silverline Chemicals
  151. SIMONA AMERICA
  152. Sinochem International
  153. Solesis
  154. Solvay
  155. SPECIFIC POLYMERS
  156. Star Thermoplastics
  157. STERLING GELATIN
  158. Strukmyer 
  159. Sumitomo Chemical
  160. SYMATESE 
  161. Teknor Apex
  162. The Leela Corporation
  163. TISSIUM
  164. TOPAS Advanced Polymers (A subsidiary of Polyplastics)
  165. Trelleborg Sealing Solutions
  166. Trellicell
  167. Trinseo
  168. Trobas Gelatine 
  169. Valens Pharmachem
  170. Versalis
  171. VIKRAM THERMO (INDIA) 
  172. Vinh Wellness
  173. Vizag Chemical
  174. Weishardt
  175. Wittenburg Group
  176. Zylog ElastoComp

Source 1: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798433
Source 2: https://www.sciencedirect.com/science/article/pii/S2405451815000434a

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com